Wang D L, Zhang X F, Jin H, Cheng X Q, Duan C X, Wang X C, Bao C J, Zhou M H, Ahmad T
Department of Epidemiology and Health Statistics, School of Public Health, Southeast University, Nanjing (210009), China.
Key Laboratory of Environmental Medicine Engineering, Ministry of Education, School of Public Health, Southeast University, Nanjing (210009), China.
Epidemiol Infect. 2018 Dec 4;147:e64. doi: 10.1017/S0950268818003175.
Rabies is one of the major public health problems in China, and the mortality rate of rabies remains the highest among all notifiable infectious diseases. A meta-analysis was conducted to investigate the post-exposure prophylaxis (PEP) vaccination rate and risk factors for human rabies in mainland China. The PubMed, Web of Science, Chinese National Knowledge Infrastructure, Chinese Science and Technology Periodical and Wanfang databases were searched for articles on rabies vaccination status (published between 2007 and 2017). In total, 10 174 human rabies cases from 136 studies were included in this meta-analysis. Approximately 97.2% (95% confidence interval (CI) 95.1-98.7%) of rabies cases occurred in rural areas and 72.6% (95% CI 70.0-75.1%) occurred in farmers. Overall, the vaccination rate in the reported human rabies cases was 15.4% (95% CI 13.7-17.4%). However, among vaccinated individuals, 85.5% (95% CI 79.8%-83.4%) did not complete the vaccination regimen. In a subgroup analysis, the PEP vaccination rate in the eastern region (18.8%, 95% CI 15.9-22.1%) was higher than that in the western region (13.3%, 95% CI 11.1-15.8%) and this rate decreased after 2007. Approximately 68.9% (95% CI 63.6-73.8%) of rabies cases experienced category-III exposures, but their PEP vaccination rate was 27.0% (95% CI 14.4-44.9%) and only 6.1% (95% CI 4.4-8.4%) received rabies immunoglobulin. Together, these results suggested that the PEP vaccination rate among human rabies cases was low in mainland China. Therefore, standardised treatment and vaccination programs of dog bites need to be further strengthened, particularly in rural areas.
狂犬病是中国主要的公共卫生问题之一,在所有法定传染病中,狂犬病的死亡率一直居高不下。开展了一项荟萃分析,以调查中国大陆人类狂犬病的暴露后预防(PEP)疫苗接种率及危险因素。检索了PubMed、科学网、中国知网、中国科技期刊数据库和万方数据库中有关狂犬病疫苗接种状况的文章(发表于2007年至2017年之间)。本荟萃分析共纳入了来自136项研究的10174例人类狂犬病病例。约97.2%(95%置信区间(CI)95.1 - 98.7%)的狂犬病病例发生在农村地区,72.6%(95%CI 70.0 - 75.1%)发生在农民中。总体而言,报告的人类狂犬病病例的疫苗接种率为15.4%(95%CI 13.7 - 17.4%)。然而,在接种疫苗的个体中,85.5%(95%CI 79.8% - 83.4%)未完成疫苗接种方案。在亚组分析中,东部地区的PEP疫苗接种率(18.8%,95%CI 15.9 - 22.1%)高于西部地区(13.3%,95%CI 11.1 - 15.8%),且该率在2007年后有所下降。约68.9%(95%CI 63.6 - 73.8%)的狂犬病病例经历了Ⅲ级暴露,但其PEP疫苗接种率为27.0%(95%CI 14.4 - 44.9%),仅6.1%(95%CI 4.4 - 8.4%)接受了狂犬病免疫球蛋白治疗。这些结果共同表明,中国大陆人类狂犬病病例中的PEP疫苗接种率较低。因此,需要进一步加强犬咬伤的标准化治疗和疫苗接种计划,特别是在农村地区。